High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer

BACKGROUND: A dose-dense strategy has been considered to improve results of adjuvant chemotherapy for breast cancer. This randomised phase II trial investigated the feasibility of this approach with sequential anthracyclines and taxanes-based chemotherapy. METHODS: Patients with high-risk node-posit...

Descripción completa

Detalles Bibliográficos
Autores principales: Brain, E, Levy, C, Serin, D, Roché, H, Spielmann, M, Delva, R, Veyret, C, Mauriac, L, Rios, M, Martin, A L, Jimenez, M, Asselain, B, Gauthier, M, Bonnetain, F, Fumoleau, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242527/
https://www.ncbi.nlm.nih.gov/pubmed/22009030
http://dx.doi.org/10.1038/bjc.2011.414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242527/
https://www.ncbi.nlm.nih.gov/pubmed/22009030
http://dx.doi.org/10.1038/bjc.2011.414

Ejemplares similares